000756 新华制药
已收盘 01-31 15:00:00
资讯
新帖
简况
新华制药:取得加工阿兹夫定片所需的《药品生产许可证》C证
财联社 · 01-18
新华制药:取得加工阿兹夫定片所需的《药品生产许可证》C证
新华制药(000756.SZ):OAB-14干混悬剂药物临床试验获批
智通财经 · 01-12
新华制药(000756.SZ):OAB-14干混悬剂药物临床试验获批
板块异动 | 阿兹夫定参与医保药品目录谈判成功 新冠药概念股尾盘拉升
智通财经 · 01-09
板块异动 | 阿兹夫定参与医保药品目录谈判成功 新冠药概念股尾盘拉升
不用抢了?退烧药、抗原短缺状况已缓解 京沪基层正陆续配备新冠口服药|传真
财联社 · 01-06
不用抢了?退烧药、抗原短缺状况已缓解 京沪基层正陆续配备新冠口服药|传真
格隆汇公告精选︱康希诺:新冠mRNA疫苗在临床研究中取得了积极的阶段性数据;尚太科技:锂离子电池负极材料项目仍处于论证阶段
格隆汇 · 01-06
格隆汇公告精选︱康希诺:新冠mRNA疫苗在临床研究中取得了积极的阶段性数据;尚太科技:锂离子电池负极材料项目仍处于论证阶段
广汽集团去年12月产销双双下滑 新华制药布洛芬新品获批生产|港股1月5日公告精选。
财联社 · 01-05
广汽集团去年12月产销双双下滑 新华制药布洛芬新品获批生产|港股1月5日公告精选。
新华制药(000756.SZ):“布洛芬混悬液”获批上市
智通财经 · 01-05
新华制药(000756.SZ):“布洛芬混悬液”获批上市
新华制药:子公司获得布洛芬混悬液药品注册证书
财联社 · 01-05
新华制药:子公司获得布洛芬混悬液药品注册证书
概念追踪 | 卫健委为基层医疗机构配齐配足中成药等 中药板块存估值提升机遇(附概念股)
智通财经 · 01-04
概念追踪 | 卫健委为基层医疗机构配齐配足中成药等 中药板块存估值提升机遇(附概念股)
12月30日新华制药(000756)龙虎榜数据:机构净买入1243.26万元,北向资金净买入4649.1万元
证券之星 · 2022-12-30
12月30日新华制药(000756)龙虎榜数据:机构净买入1243.26万元,北向资金净买入4649.1万元
布洛芬龙头狂演“过山车” 主力资金抽身而逃 新华制药(000756.SZ)跌停登龙虎榜
智通财经 · 2022-12-27
布洛芬龙头狂演“过山车” 主力资金抽身而逃 新华制药(000756.SZ)跌停登龙虎榜
12月27日新华制药(000756)龙虎榜数据:机构净卖出5975.62万元
证券之星 · 2022-12-27
12月27日新华制药(000756)龙虎榜数据:机构净卖出5975.62万元
异动快报:新华制药(000756)12月27日10点53分触及跌停板
证券之星 · 2022-12-27
异动快报:新华制药(000756)12月27日10点53分触及跌停板
新华制药(000756.SZ)向激励对象授予175万份预留股票期权 行权价为7.96元/份
智通财经 · 2022-12-25
新华制药(000756.SZ)向激励对象授予175万份预留股票期权 行权价为7.96元/份
港股制药概念走势分化:和铂医药涨28% 新华制药跌7%
财联社 · 2022-12-23
港股制药概念走势分化:和铂医药涨28% 新华制药跌7%
【AH互动】新华制药(00719)AH股均由升转跌 多地免费派退烧药
凤凰网港股 · 2022-12-23
【AH互动】新华制药(00719)AH股均由升转跌 多地免费派退烧药
港股12月23日早报:ADR指数跌1.7% 摩根大通增持新华制药H股
财联社 · 2022-12-23
港股12月23日早报:ADR指数跌1.7% 摩根大通增持新华制药H股
国企改革板块12月22日跌0.61%,新华制药领跌,北向资金增持4.99亿元
证券之星 · 2022-12-23
国企改革板块12月22日跌0.61%,新华制药领跌,北向资金增持4.99亿元
12月22日新华制药(000756)龙虎榜数据:北向资金净卖出705.6万元
证券之星 · 2022-12-22
12月22日新华制药(000756)龙虎榜数据:北向资金净卖出705.6万元
退烧药供不应求还将持续一段时间
虎嗅 · 2022-12-22
退烧药供不应求还将持续一段时间
暂无数据
公司概况
公司名称:
山东新华制药股份有限公司
所属行业:
医药制造业
上市日期:
1997-08-06
主营业务:
山东新华制药股份有限公司主要从事开发、制造及销售化学原料药、制剂以及化工产品;公司的主要产品有解热镇痛类原料药、片剂、针剂、胶囊剂、医药中间体。公司拥有技术创新优势,现为高新技术企业、国家火炬计划重点高新技术企业、国家火炬计划生物医药产业基地骨干企业,拥有国家级企业技术中心,建有企业博士后科研工作站。“基于产业化关键技术的咖啡因绿色制备体系构建与规模开发”荣获2018年度山东省科学技术进步二等奖。上半年获得专利授权10件。公司被公示为“山东省技术创新示范企业”,被评为山东人才工作先进单位。
发行价格:
3.45
{"stockData":{"symbol":"000756","market":"SZ","secType":"STK","nameCN":"新华制药","latestPrice":27.46,"timestamp":1675148625000,"preClose":27.21,"halted":0,"volume":16393007,"delay":0,"floatShares":441000000,"shares":674000000,"eps":0.5293,"marketStatus":"已收盘","marketStatusCode":5,"change":0.25,"latestTime":"01-31 15:00:00","open":27.22,"high":27.47,"low":26.91,"amount":447000000,"amplitude":0.0206,"askPrice":27.47,"askSize":471,"bidPrice":27.46,"bidSize":615,"shortable":0,"etf":0,"ttmEps":0.5293,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1675215000000},"adr":0,"adjPreClose":27.21,"symbolType":"stock","highLimit":29.93,"lowLimit":24.49,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":673887535,"pbRate":4.62,"roa":"--","roe":"7.77%","epsLYR":0.56,"committee":-0.337905,"marketValue":18505000000,"floatMarketCap":12099000000,"peRate":51.879844,"changeRate":0.0092,"turnoverRate":0.0372,"status":0},"requestUrl":"/m/hq/s/000756/tweets","defaultTab":"tweets","newsList":[{"id":"2304688536","title":"新华制药:取得加工阿兹夫定片所需的《药品生产许可证》C证","url":"https://stock-news.laohu8.com/highlight/detail?id=2304688536","media":"财联社","top":-1,"share":"https://www.laohu8.com/m/news/2304688536?lang=zh_CN&edition=full","pubTime":"2023-01-18 16:58","pubTimestamp":1674032329,"startTime":"0","endTime":"0","summary":"【新华制药:取得加工阿兹夫定片所需的《药品生产许可证》C证】财联社1月18日电,新华制药公告,2023年1月18日,公司取得山东省药品监督管理局颁发的关于公司生产加工阿兹夫定片所需的《药品生产许可证》C证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://www.cls.cn/detail/1244680","is_publish_highlight":false},{"id":"2302385863","title":"新华制药(000756.SZ):OAB-14干混悬剂药物临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2302385863","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2302385863?lang=zh_CN&edition=full","pubTime":"2023-01-12 16:49","pubTimestamp":1673513347,"startTime":"0","endTime":"0","summary":"据悉,OAB-14是一类全新作用机制的抗AD候选药物,在已完成的药效学研究表明OAB-14能显著减少脑内β淀粉样蛋白沉积。目前靶向Aβ清除的药物只有FDA批准的渤健/卫材的单抗药物aducanumab,但尚无靶向Aβ清除的多靶点小分子抗AD药物进入临床试验或上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/861026.html","is_publish_highlight":false},{"id":"2302728613","title":"板块异动 | 阿兹夫定参与医保药品目录谈判成功 新冠药概念股尾盘拉升","url":"https://stock-news.laohu8.com/highlight/detail?id=2302728613","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2302728613?lang=zh_CN&edition=full","pubTime":"2023-01-09 14:48","pubTimestamp":1673246905,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,1月9日,受阿兹夫定参与医保药品目录谈判成功消息影响,A股新冠药概念股拉升,截至发稿,广生堂直线拉涨7%,众生药业、新华制药、舒泰神、盘龙药业等股拉升上涨。1月8日,2022年国家医保药品目录谈判工作正式结束。其中,阿兹夫定片、清肺排毒颗粒谈判成功,Paxlovid因生产企业辉瑞报价高未能成功。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/858931.html","is_publish_highlight":false},{"id":"2301757221","title":"不用抢了?退烧药、抗原短缺状况已缓解 京沪基层正陆续配备新冠口服药|传真","url":"https://stock-news.laohu8.com/highlight/detail?id=2301757221","media":"财联社","top":-1,"share":"https://www.laohu8.com/m/news/2301757221?lang=zh_CN&edition=full","pubTime":"2023-01-06 20:09","pubTimestamp":1673006994,"startTime":"0","endTime":"0","summary":"对于近段时间供应紧张的涉疫物资,财联社记者实地走访和线上访问了诸多涉疫物资生产、经营和使用企业、单位,总体来看,退烧药物和抗原检测试剂短缺状况已经得到较大缓解,消费者已经可以通过多种渠道购买。","market":"sh","thumbnail":"https://img.cls.cn/images/20230106/5Q3vq8EthW.jpg@!thumb_flash","type":0,"news_type":0,"thumbnails":["https://img.cls.cn/images/20230106/5Q3vq8EthW.jpg@!thumb_flash"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://m.cls.cn/depth/1233396","is_publish_highlight":false},{"id":"2301265250","title":"格隆汇公告精选︱康希诺:新冠mRNA疫苗在临床研究中取得了积极的阶段性数据;尚太科技:锂离子电池负极材料项目仍处于论证阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2301265250","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2301265250?lang=zh_CN&edition=full","pubTime":"2023-01-06 00:11","pubTimestamp":1672935103,"startTime":"0","endTime":"0","summary":"振华新材(688707.SH):2022年度净利预增195.70%-215.09%;数源科技(000909.SZ):目前没有与\"元宇宙\"相关的业务","market":"us","thumbnail":"https://img7.gelonghui.com/column/2/108.png","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/108.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://www.gelonghui.com/p/572676","is_publish_highlight":false},{"id":"2301259499","title":"广汽集团去年12月产销双双下滑 新华制药布洛芬新品获批生产|港股1月5日公告精选。","url":"https://stock-news.laohu8.com/highlight/detail?id=2301259499","media":"财联社","top":-1,"share":"https://www.laohu8.com/m/news/2301259499?lang=zh_CN&edition=full","pubTime":"2023-01-05 20:55","pubTimestamp":1672923355,"startTime":"0","endTime":"0","summary":"晚间重要公告有:广汽集团2022年12月汽车产量为19.97万辆,同比下降25.46%;汽车销量为20.6万辆,同比下降11.84%。山东新华制药股份披露子公司布洛芬混悬液产品获监管批准生产。","market":"hk","thumbnail":"https://img.cls.cn/images/20230105/kCKYHTn0bM.jpeg@!thumb_flash","type":0,"news_type":0,"thumbnails":["https://img.cls.cn/images/20230105/kCKYHTn0bM.jpeg@!thumb_flash"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://m.cls.cn/depth/1232086","is_publish_highlight":false},{"id":"2301823961","title":"新华制药(000756.SZ):“布洛芬混悬液”获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2301823961","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2301823961?lang=zh_CN&edition=full","pubTime":"2023-01-05 16:48","pubTimestamp":1672908522,"startTime":"0","endTime":"0","summary":"智通财经APP讯,新华制药(000756.SZ)公告,近日,公司全资子公司新华制药(高密)有限公司(“高密公司”)收到国家药品监督管理局核准签发的布洛芬混悬液《药品注册证书》。据悉,布洛芬混悬液用于儿童普通感冒或流行性感冒引起的发热;也用于缓解儿童轻至中度疼痛,如头痛、关节痛、偏头痛、牙痛、肌肉痛、神经痛。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/857656.html","is_publish_highlight":false},{"id":"2301396992","title":"新华制药:子公司获得布洛芬混悬液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2301396992","media":"财联社","top":-1,"share":"https://www.laohu8.com/m/news/2301396992?lang=zh_CN&edition=full","pubTime":"2023-01-05 16:44","pubTimestamp":1672908258,"startTime":"0","endTime":"0","summary":"【新华制药:子公司获得布洛芬混悬液药品注册证书】财联社1月5日电,新华制药公告,近日,公司之全资子公司新华制药(高密)有限公司收到国家药品监督管理局核准签发的布洛芬混悬液《药品注册证书》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://www.cls.cn/detail/1231746","is_publish_highlight":false},{"id":"2300496629","title":"概念追踪 | 卫健委为基层医疗机构配齐配足中成药等 中药板块存估值提升机遇(附概念股)","url":"https://stock-news.laohu8.com/highlight/detail?id=2300496629","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2300496629?lang=zh_CN&edition=full","pubTime":"2023-01-04 07:35","pubTimestamp":1672788903,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,1月3日,国务院联防联控机制公告称,各地要按照服务人口15%-20%的标准,为基层医疗卫生机构配齐配足新冠病毒感染对症治疗的中成药、退热药、止咳药及抗原检测试剂盒配备,确保机构可用量始终保持在2周以上。机构继续战略看好中药的长期机遇,未来在国家政策整体支持下,中药仍有板块性估值提升机遇。消息称,为了保证市场供应,新华制药以及亨迪药业均决定扩产。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/856707.html","is_publish_highlight":false},{"id":"2295979357","title":"12月30日新华制药(000756)龙虎榜数据:机构净买入1243.26万元,北向资金净买入4649.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2295979357","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2295979357?lang=zh_CN&edition=full","pubTime":"2022-12-30 17:01","pubTimestamp":1672390894,"startTime":"0","endTime":"0","summary":"沪深交易所2022年12月30日公布的交易公开信息显示,新华制药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。截至2022年12月30日收盘,新华制药报收于30.1元,下跌7.36%,换手率12.36%,成交量53.94万手,成交额16.59亿元。从龙虎榜公布的当日买卖数据来看,机构合计净买入1243.26万元,北向资金合计净买入4649.1万元。新华制药的关注点:1、18年3月,与阿里巴巴集团共同签署框架合作协议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022123000008306.shtml","is_publish_highlight":false},{"id":"2294649021","title":"布洛芬龙头狂演“过山车” 主力资金抽身而逃 新华制药(000756.SZ)跌停登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2294649021","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2294649021?lang=zh_CN&edition=full","pubTime":"2022-12-27 18:45","pubTimestamp":1672137940,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,12月27日,布洛芬大户新华制药跌停,收报34.21元,跌幅10.00%。自“退烧药”爆火以来,市场上出现了短暂抢购防疫药品的现象,部分药品如布洛芬等脱销,布洛芬概念龙头新华制药的股价也迅速猛增。截至2022年12月27日,新华制药跌停,收盘价为34.21元/股,当日下跌幅度为10.00%。备受追捧后,新华制药也受到了监管部门的关注。12月14日下午,新华制药发布公告称,收到了深交所关注函。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/853083.html","is_publish_highlight":false},{"id":"2294728643","title":"12月27日新华制药(000756)龙虎榜数据:机构净卖出5975.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2294728643","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2294728643?lang=zh_CN&edition=full","pubTime":"2022-12-27 17:02","pubTimestamp":1672131757,"startTime":"0","endTime":"0","summary":"沪深交易所2022年12月27日公布的交易公开信息显示,新华制药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。截至2022年12月27日收盘,新华制药报收于34.21元,下跌10.0%,跌停,换手率14.21%,成交量62.0万手,成交额21.68亿元。从龙虎榜公布的当日买卖数据来看,机构合计净卖出5975.62万元。根据近五年财报数据,证券之星估值分析工具显示,新华制药行业内竞争力的护城河良好,盈利能力较差,营收成长性良好。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022122700006149.shtml","is_publish_highlight":false},{"id":"2294615791","title":"异动快报:新华制药(000756)12月27日10点53分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2294615791","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2294615791?lang=zh_CN&edition=full","pubTime":"2022-12-27 10:55","pubTimestamp":1672109720,"startTime":"0","endTime":"0","summary":"12月27日盘中消息,10点53分新华制药触及跌停板。目前价格34.21,下跌10.0%。其所属行业化学制药目前下跌。12月26日的资金流向数据方面,主力资金净流出1753.07万元,占总成交额0.63%,游资资金净流入96.81万元,占总成交额0.03%,散户资金净流入1656.26万元,占总成交额0.6%。近5日资金流向一览见下表:新华制药主要指标及行业内排名如下:新华制药个股概况:以上内容由证券之星根据公开信息整理,与本站立场无关。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022122700003232.shtml","is_publish_highlight":false},{"id":"2294450299","title":"新华制药(000756.SZ)向激励对象授予175万份预留股票期权 行权价为7.96元/份","url":"https://stock-news.laohu8.com/highlight/detail?id=2294450299","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2294450299?lang=zh_CN&edition=full","pubTime":"2022-12-25 16:04","pubTimestamp":1671955472,"startTime":"0","endTime":"0","summary":"智通财经APP讯,新华制药(000756.SZ)发布公告,公司2021年股票期权激励计划(草案)》规定的各项授予条件已经成就,现预留部分激励对象已确定,公司于2022年12月23日召开第十届董事会2022年第四次临时会议和第十届监事会2022年第一次临时会议,审议通过了《关于向激励对象授予预留股票期权的议案》。根据公司2021年第一次临时股东大会、2021年第二次A股类别股东大会的授权,公司董事会同意以2022年12月26日为预留授予日,向符合条件的35名激励对象授予175万份预留股票期权,行权价格为7.96元/份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/852387.html","is_publish_highlight":false},{"id":"2293563941","title":"港股制药概念走势分化:和铂医药涨28% 新华制药跌7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2293563941","media":"财联社","top":-1,"share":"https://www.laohu8.com/m/news/2293563941?lang=zh_CN&edition=full","pubTime":"2022-12-23 14:02","pubTimestamp":1671775341,"startTime":"0","endTime":"0","summary":"财联社12月23日电,制药概念港股午后走势分化。截至发稿,和铂医药涨28%,诺诚健华涨13%,德琪医药涨8%。山东新华制药股份冲高回落,午后反跌7%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://www.cls.cn/detail/1220896","is_publish_highlight":false},{"id":"2293555224","title":"【AH互动】新华制药(00719)AH股均由升转跌 多地免费派退烧药","url":"https://stock-news.laohu8.com/highlight/detail?id=2293555224","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2293555224?lang=zh_CN&edition=full","pubTime":"2022-12-23 11:29","pubTimestamp":1671766177,"startTime":"0","endTime":"0","summary":"山东新华制药股份盘中冲高回落,最高曾升至11.9港元,涨逾5%,最新转跌6.06%,报10.54港元,成交额4.19亿港元。另外,A股新华制药同步走势,最新报36.35元人民币,跌7.51%,成交额18.82亿元人民币。其他消息方面,根据联交所最新权益披露资料显示,2022年12月16日,山东新华制药股份获摩通以每股均价14.1943港元增持好仓757.4万股,涉资约1.08亿港元。但于12月15日,摩通减持山东新华制药股份400.4万股,每股作价12.3058港元,总金额约为4927.24万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=cadaa65c9c3c112586422adddd0895d7","is_publish_highlight":false},{"id":"2293536865","title":"港股12月23日早报:ADR指数跌1.7% 摩根大通增持新华制药H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2293536865","media":"财联社","top":-1,"share":"https://www.laohu8.com/m/news/2293536865?lang=zh_CN&edition=full","pubTime":"2022-12-23 07:53","pubTimestamp":1671753196,"startTime":"0","endTime":"0","summary":"今日港股早报主要内容有:港股ADR指数下跌,按比例计算较香港收市跌331.52点或1.71%。 圣诞节港股和港股通(南向)12月26日至12月27日休市两天。香港政府公布“创科发展蓝图”。摩根大通增持山东新华制药股份H股约1.075亿港元。","market":"sh","thumbnail":"https://img.cls.cn/images/20221223/i4lPa7JnIS.jpg@!thumb_flash","type":0,"news_type":0,"thumbnails":["https://img.cls.cn/images/20221223/i4lPa7JnIS.jpg@!thumb_flash"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://m.cls.cn/depth/1220541","is_publish_highlight":false},{"id":"2293553437","title":"国企改革板块12月22日跌0.61%,新华制药领跌,北向资金增持4.99亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2293553437","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2293553437?lang=zh_CN&edition=full","pubTime":"2022-12-23 04:31","pubTimestamp":1671741087,"startTime":"0","endTime":"0","summary":"12月22日国企改革板块较上一交易日下跌0.61%,新华制药领跌。当日上证指数报收于3054.43,下跌0.46%。深证成指报收于10876.31,下跌0.33%。国企改革板块个股资金流向见下表:北向资金方面,当日国企改革板块北向资金持股市值为4104.89亿元,增持4.99亿元。减持持最多的是国电南瑞,减持了0.83亿元。国企改革板块北向资金持股变动明细见下表:以上内容由证券之星根据公开信息整理,与本站立场无关。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022122300001232.shtml","is_publish_highlight":false},{"id":"2293047923","title":"12月22日新华制药(000756)龙虎榜数据:北向资金净卖出705.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2293047923","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2293047923?lang=zh_CN&edition=full","pubTime":"2022-12-22 17:01","pubTimestamp":1671699686,"startTime":"0","endTime":"0","summary":"沪深交易所2022年12月22日公布的交易公开信息显示,新华制药因日跌幅偏离值达到7%的前5只证券登上龙虎榜。截至2022年12月22日收盘,新华制药报收于39.3元,下跌8.65%,换手率16.74%,成交量73.04万手,成交额29.31亿元。从龙虎榜公布的当日买卖数据来看,北向资金合计净卖出705.6万元。根据近五年财报数据,证券之星估值分析工具显示,新华制药行业内竞争力的护城河良好,盈利能力较差,营收成长性良好。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022122200006082.shtml","is_publish_highlight":false},{"id":"2293342384","title":"退烧药供不应求还将持续一段时间","url":"https://stock-news.laohu8.com/highlight/detail?id=2293342384","media":"虎嗅","top":-1,"share":"https://www.laohu8.com/m/news/2293342384?lang=zh_CN&edition=full","pubTime":"2022-12-22 00:05","pubTimestamp":1671638700,"startTime":"0","endTime":"0","summary":"产能不缺,但释放需要时间","market":"sh","thumbnail":"https://img.huxiucdn.com/article/cover/202212/21/215330819970.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg","type":0,"news_type":0,"thumbnails":["https://img.huxiucdn.com/article/cover/202212/21/215330819970.jpg?imageView2/1/w/720/h/405/|imageMogr2/strip/interlace/1/quality/85/format/jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://www.huxiu.com/article/748822.html","is_publish_highlight":false}],"profile":{"ret":0,"listingDate":"1997-08-06","address":"山东省淄博市张店区高新技术产业开发区化工区","stockEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.096},{"period":"3month","weight":0.4224},{"period":"6month","weight":0.4304},{"period":"1year","weight":2.109},{"period":"ytd","weight":-0.096}],"companyName":"山东新华制药股份有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"67388万元","compareEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":0.0583},{"period":"3month","weight":0.1011},{"period":"6month","weight":0.0334},{"period":"1year","weight":-0.0274},{"period":"ytd","weight":0.0583}],"survey":" 山东新华制药股份有限公司主要从事开发、制造及销售化学原料药、制剂以及化工产品;公司的主要产品有解热镇痛类原料药、片剂、针剂、胶囊剂、医药中间体。公司拥有技术创新优势,现为高新技术企业、国家火炬计划重点高新技术企业、国家火炬计划生物医药产业基地骨干企业,拥有国家级企业技术中心,建有企业博士后科研工作站。“基于产业化关键技术的咖啡因绿色制备体系构建与规模开发”荣获2018年度山东省科学技术进步二等奖。上半年获得专利授权10件。公司被公示为“山东省技术创新示范企业”,被评为山东人才工作先进单位。","serverTime":1675175896439,"listedPrice":3.45,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.11.11","shortVersion":"4.11.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新华制药,000756,新华制药股票,新华制药股票老虎,新华制药股票老虎国际,新华制药行情,新华制药股票行情,新华制药股价,新华制药股市,新华制药股票价格,新华制药股票交易,新华制药股票购买,新华制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新华制药(000756)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新华制药(000756)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}